AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home hLife Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Peptide-based henipavirus entry inhibitors as pandemic countermeasures

Qian Wang, Yuanzhou Wang, Lu Lu, Shibo Jiang( )
Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
hLife
Volume 4 Issue 8,
August 2026
Pages 489-493
DOI: 10.1016/j.hlife.2026.04.002

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Wang Q, Wang Y, Lu L, et al. Peptide-based henipavirus entry inhibitors as pandemic countermeasures. hLife, 2026, 4(8): 489-493. https://doi.org/10.1016/j.hlife.2026.04.002

1

Views

0

Crossref
Received: 12 March 2026
Revised: 22 April 2026
Accepted: 22 April 2026
Published: 01 August 2026
© 2026 The Author(s).

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).